(Q50478947)

14 March 2018

title

Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy. (English)

1 reference

14 March 2018

1 reference

1 reference

meningococcal meningitis

1 reference

based on heuristic

inferred from title

author name string

Erasmo Barbante Casella

1

1 reference

14 March 2018

Saul Cypel

2

1 reference

14 March 2018

André Alexandre Osmo

3

1 reference

14 March 2018

Yassuhiko Okay

4

1 reference

14 March 2018

Beatriz Helena Lefèvre

5

1 reference

14 March 2018

Ida Lichtig

6

1 reference

14 March 2018

Maria Joaquina Marques-Dias

7

1 reference

14 March 2018

publication date

1 June 2004

1 reference

14 March 2018

Arquivos de Neuro-Psiquiatria

published in

1 reference

14 March 2018

volume

62

1 reference

14 March 2018

issue

2B

1 reference

14 March 2018

page(s)

421-428

1 reference

14 March 2018

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Glucocorticoids in central nervous system bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Complications and sequelae of meningococcalinfections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

21 January 2018

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Cytokines, chemokines and other effector molecules involved in meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000300009

10.1590/S0004-282X2004000300009

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018